Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages

  Jenkins, Alicia ^a,b   Zhang, Sarah X ^a   Gosmanova, Albina ^a   Aston, Christopher ^c   Dashti, Azar ^a   Baker, Mary Zoe ^a   Lyons, Timothy ^a,c,d   Ma, Jian Xing ^a  

^a Endocrinology   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical research; Human; Inflammation; Pigment Epithelium Derived Factor; Renal dysfunction; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CREATININE; DIABETES MELLITUS, TYPE 2; EYE PROTEINS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; SERPINS;

EID: 52949093160     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.06.019     Document Type: Article

References (10)

1. Tombran-Tink J., and Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 4 (2003) 628-636
2. Jenkins A.J., Zhang S.X., Rowley K.G., Karschimkus C.S., Nelson C.L., Chung J.S., et al. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabet. Med. 24 (2007) 1345-1351
3. Zhang S.X., Wang J.J., Gao G., Shao C., Mott R., and Ma J.X. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J. 20 (2006) 323-325
4. Wang J.J., Zhang S.X., Mott R., Knapp R.R., Cao W., Lau K., et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes 55 (2006) 1678-1685
5. Zhang S.X., Wang J.J., Gao G., Parke K., and Ma J.X. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol. 37 (2006) 1-12
6. Wang J.J., Zhang S.X., Lu K., Chen Y., Mott R., Sato S., et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 54 (2005) 243-250
7. Ogata N., Matsuoka M., Matsuyama K., Shima C., Tajika A., Nishiyama T., et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J. Clin. Endocrinol. Metab. 92 (2007) 1176-1179
8. Chen H.B., Jia W.P., Lu J.X., Bao Y.Q., Li Q., Lu F.D., et al. Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy. Zhonghua. Yi. Xue. Za. Zhi. 87 (2007) 1230-1233
9. Yamagishi S., Adachi H., Abe A., Yashiro T., Enomoto M., Furuki K., et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J. Clin. Endocrinol. Metab. 91 (2006) 2447-2450
10. Motomiya Y., Yamagishi S., Adachi H., and Abe A. Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease. Clin. Chem. 52 (2006) 1970-1971